Investigation of the Value of Precipitins in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients with a Positive Marker for Aspergillus Species

Overview

Journal Med Mycol

Publisher Oxford University Press

Specialties Microbiology
Veterinary Medicine

Date 2022 May 23

PMID 35604675

Authors

A P Bellanger

S Lallemand

A Tumasyan Horikian

J C Navellou

C Barrera

A Rouzet

E Scherer

G Reboux

G Piton

L Millon

Affiliations

Soon will be listed here.

Abstract

Lay Summary: This study showed retrospectively that precipitin assays, such as electrosyneresis, could be helpful to distinguish between colonization and infection with Aspergillus fumigatus during the management of severe acute respiratory syndrome Coronavirus-2 (SARS CoV-2) patients in an intensive care unit.

Citing Articles

Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.

Zhou X, Wu X, Chen Z, Cui X, Cai Y, Liu Y Front Cell Infect Microbiol. 2023; 13:1287496.

PMID: 38076456 PMC: 10703051. DOI: 10.3389/fcimb.2023.1287496.

-SARS-CoV-2 Coinfection: What Is Known?.

Castro-Fuentes C, Reyes-Montes M, Frias-De-Leon M, Valencia-Ledezma O, Acosta-Altamirano G, Duarte-Escalante E Pathogens. 2022; 11(11).

PMID: 36364979 PMC: 9694759. DOI: 10.3390/pathogens11111227.

References

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Barrera C, Richaud-Thiriez B, Rocchi S, Rognon B, Roussel S, Grenouillet F . New Commercially Available IgG Kits and Time-Resolved Fluorometric IgE Assay for Diagnosis of Allergic Bronchopulmonary Aspergillosis in Patients with Cystic Fibrosis. Clin Vaccine Immunol. 2015; 23(3):196-203. PMC: 4783427. DOI: 10.1128/CVI.00498-15. View

Rocchi S, Reboux G, Larosa F, Scherer E, Daguindeau E, Berceanu A . Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home. Indoor Air. 2014; 24(6):652-61. DOI: 10.1111/ina.12108. View

Johannson K, Barnes H, Bellanger A, Dalphin J, Fernandez Perez E, Flaherty K . Exposure Assessment Tools for Hypersensitivity Pneumonitis. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2020; 17(12):1501-1509. PMC: 7706597. DOI: 10.1513/AnnalsATS.202008-942ST. View

Bellanger A, Millon L, Berceanu A, Grenouillet F, Grenouillet F, Larosa F . Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients. Med Mycol. 2015; 53(7):760-4. DOI: 10.1093/mmy/myv051. View

Millon L, Roussel S, Rognon B, Quadroni M, Salamin K, Reboux G . Aspergillus species recombinant antigens for serodiagnosis of farmer's lung disease. J Allergy Clin Immunol. 2012; 130(3):803-805.e6. DOI: 10.1016/j.jaci.2012.03.039. View

Selman M, Pardo A, King Jr T . Hypersensitivity pneumonitis: insights in diagnosis and pathobiology. Am J Respir Crit Care Med. 2012; 186(4):314-24. DOI: 10.1164/rccm.201203-0513CI. View

Alanio A, Delliere S, Fodil S, Bretagne S, Megarbane B . Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020; 8(6):e48-e49. PMC: 7239617. DOI: 10.1016/S2213-2600(20)30237-X. View

Gangneux J, Dannaoui E, Fekkar A, Luyt C, Botterel F, de Prost N . Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir Med. 2021; 10(2):180-190. PMC: 8626095. DOI: 10.1016/S2213-2600(21)00442-2. View

10.

Rutsaert L, Steinfort N, Van Hunsel T, Bomans P, Naesens R, Mertes H . COVID-19-associated invasive pulmonary aspergillosis. Ann Intensive Care. 2020; 10(1):71. PMC: 7265874. DOI: 10.1186/s13613-020-00686-4. View

11.

Koehler P, Bassetti M, Chakrabarti A, Chen S, Colombo A, Hoenigl M . Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2020; 21(6):e149-e162. PMC: 7833078. DOI: 10.1016/S1473-3099(20)30847-1. View

12.

Bellanger A, Reboux G, Rouzet A, Barrera C, Rocchi S, Scherer E . Hypersensitivity pneumonitis: A new strategy for serodiagnosis and environmental surveys. Respir Med. 2019; 150:101-106. DOI: 10.1016/j.rmed.2019.02.019. View

13.

Fenoglio C, Reboux G, Sudre B, Mercier M, Roussel S, Cordier J . Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J. 2006; 29(4):706-12. DOI: 10.1183/09031936.00001006. View

14.

Song Y, Shin H . COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis. Infect Chemother. 2020; 52(1):110-112. PMC: 7113449. DOI: 10.3947/ic.2020.52.1.110. View

15.

Vuitton D, Vuitton L, Seilles E, Galanaud P . A plea for the pathogenic role of immune complexes in severe Covid-19. Clin Immunol. 2020; 217:108493. PMC: 7278649. DOI: 10.1016/j.clim.2020.108493. View